Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Capital Leases (2018)

Champions Oncology has reported Capital Leases over the past 1 years, most recently at $95000.0 for Q4 2018.

  • Quarterly results put Capital Leases at $95000.0 for Q4 2018, changed N/A from a year ago — trailing twelve months through Oct 2018 was $95000.0 (changed N/A YoY), and the annual figure for FY2018 was $17000.0, changed.
  • Capital Leases for Q4 2018 was $95000.0 at Champions Oncology, down from $148000.0 in the prior quarter.
  • Over the last five years, Capital Leases for CSBR hit a ceiling of $148000.0 in Q3 2018 and a floor of $17000.0 in Q2 2018.